When anti-VEGF was first applied to the treatment of ROPs, IVB was performed after laser treatment, because with the uncertain effect on ROP at that time clinicians were reluctant to use bevacizumab as an initial treatment. The gene discussed is VEGFA; the disease is retinopathy of prematurity.